Potent aminocyclitol glucocerebrosidase inhibitors are subnanomolar pharmacological chaperones for treating gaucher disease.

Potent aminocyclitol glucocerebrosidase inhibitors are subnanomolar pharmacological chaperones for treating gaucher disease.

Amino-myo-inositol derivatives have been found to be potent inhibitors of glucocerebrosidase (GCase), the β-glucosidase enzyme deficient in Gaucher disease (GD). When tested using lymphoblasts derived from patients with GD homozygous for N370S or L444P mutations, the compounds enhanced GCase activit...

Полное описание

Библиографические подробности
Главные авторы:	Trapero, A, González-Bulnes, P, Butters, T, Llebaria, A
Формат:	Journal article
Язык:	English
Опубликовано:	2012

Схожие документы

Polyhydroxylated bicyclic isoureas and guanidines are potent glucocerebrosidase inhibitors and nanomolar enzyme activity enhancers in Gaucher cells.
по: Trapero, A, и др.
Опубликовано: (2011)

Chaperoning glucocerebrosidase: a therapeutic strategy for both Gaucher disease and Parkinsonism
по: Benjamin McMahon, и др.
Опубликовано: (2016-01-01)

Rational design and synthesis of highly potent pharmacological chaperones for treatment of N370S mutant Gaucher disease.
по: Wang, G, и др.
Опубликовано: (2009)

Synthesis of N-substituted ε-hexonolactams as pharmacological chaperones for the treatment of N370S mutant Gaucher disease.
по: Wang, G, и др.
Опубликовано: (2012)

Progranulin Recruits HSP70 to β-Glucocerebrosidase and Is Therapeutic Against Gaucher Disease
по: Jinlong Jian, и др.
Опубликовано: (2016-11-01)

Effect of macrophage-targeted glucocerebrosidase(alglucerase) on hypolipidaemia of type 1 Gaucher disease(GD)
по: Mistry, P, и др.
Опубликовано: (1997)

Docking study and biological evaluation of pyrrolidine-based iminosugars as pharmacological chaperones for Gaucher disease
по: Kato, A, и др.
Опубликовано: (2016)

Abstract P-43: Effect of Glucocerebrosidase Dysfunction on the Pool of Plasma Exosomes of Patients with Gaucher Disease
по: Luiza A. Garaeva, и др.
Опубликовано: (2021-06-01)

N- and C-alkylation of seven-membered iminosugars generates potent glucocerebrosidase inhibitors and F508del-CFTR correctors.
по: Désiré, J, и др.
Опубликовано: (2014)

Engineering synthetic and recombinant human lysosomal β-glucocerebrosidase for enzyme replacement therapy for Gaucher disease
по: Figueiredo, Lílian L. S., и др.
Опубликовано: (2024)

Engineering synthetic and recombinant human lysosomal β-glucocerebrosidase for enzyme replacement therapy for Gaucher disease
по: Lílian L. Souza Figueiredo, и др.
Опубликовано: (2024-10-01)

Gaucher disease.
по: Butters, T
Опубликовано: (2007)

Concise and enantioselective synthesis of the aminocyclitol core of hygromycin A.
по: Donohoe, T, и др.
Опубликовано: (2005)

Recent progress in the synthesis of six-membered aminocyclitols (2008-2017)
по: William A. Donaldson
Опубликовано: (2018-05-01)

Therapeutic delivery of recombinant glucocerebrosidase enzyme-containing extracellular vesicles to human cells from Gaucher disease patients
по: Keatdamrong Janpipatkul, и др.
Опубликовано: (2024-10-01)

High throughput screening for small molecule therapy for Gaucher disease using patient tissue as the source of mutant glucocerebrosidase.
по: Ehud Goldin, и др.
Опубликовано: (2012-01-01)

in silico identification of genetic variants in glucocerebrosidase (GBA) gene involved in Gaucher’s disease using multiple software tools.
по: Madhumathi eManickam, и др.
Опубликовано: (2014-05-01)

Amphiphilic 1-deoxynojirimycin derivatives through click strategies for chemical chaperoning in N370S Gaucher cells.
по: Diot, J, и др.
Опубликовано: (2011)

A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease
по: Wendy Westbroek, и др.
Опубликовано: (2016-07-01)

A myo-inositol dehydrogenase involved in aminocyclitol biosynthesis of hygromycin A
по: Michael O. Akintubosun, и др.
Опубликовано: (2024-03-01)

Second-Generation Pharmacological Chaperones: Beyond Inhibitors
по: My Lan Tran, и др.
Опубликовано: (2020-07-01)

Hydrophobic Rose Bengal Derivatives Exhibit Submicromolar-to-Subnanomolar Activity against Enveloped Viruses
по: Anna A. Rubekina, и др.
Опубликовано: (2022-11-01)

Activation and Purification of ß‐Glucocerebrosidase by Exploiting its Transporter LIMP‐2 – Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease
по: Jan Philipp Dobert, и др.
Опубликовано: (2024-07-01)

A NOVEL SYNTHETIC AND RECOMBINANT GLUCOCEREBROSIDASE FOR GAUCHER DISEASE: IN SILICO MOLECULAR EVOLUTION AND GENE THERAPY APPROACHES TO ENHANCE ENZYME ACTIVITY
по: LLS Figueiredo, и др.
Опубликовано: (2023-10-01)

INVESTIGATIONS ON THE RESISTANCE OF COMMENSAL SWINE ESCHERICHIA COLI TO SOME AMINOGLYCOSIDES-AMINOCYCLITOLS
по: Valentina Urumova, и др.
Опубликовано: (2016-03-01)

Design of a New α-1-C-Alkyl-DAB Derivative Acting as a Pharmacological Chaperone for β-Glucocerebrosidase Using Ligand Docking and Molecular Dynamics Simulation
по: Izumi Nakagome, и др.
Опубликовано: (2018-10-01)

Different and unusual presentation of Gaucher’s disease with the same mutation in the glucocerebrosidase enzyme (F266L) in two patients: a case report
по: Bijan Keikhaei, и др.
Опубликовано: (2024-11-01)

Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease.
по: Brumshtein, B, и др.
Опубликовано: (2007)

Regioselectivity in the Ring Opening of Epoxides for the Synthesis of Aminocyclitols from D-(-)-Quinic Acid
по: Shu-Yu Yang, и др.
Опубликовано: (2012-04-01)

Synthesis of a new class of aminocyclitol analogues with the conduramine D-2 configuration
по: Latif Kelebekli, и др.
Опубликовано: (2010-02-01)

Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology
по: Alba Navarro-Romero, и др.
Опубликовано: (2022-10-01)

Quantification in the subnanomolar range of phospholipids and neutral lipids by monodimensional thin-layer chromatography and image analysis
по: J I Ruiz, и др.
Опубликовано: (1997-07-01)

Small Molecule Chaperones for the Treatment of Gaucher Disease and GBA1-Associated Parkinson Disease
по: Tae-Un Han, и др.
Опубликовано: (2020-05-01)

Cellular and biochemical response to chaperone versus substrate reduction therapies in neuropathic Gaucher disease
по: Margarita M. Ivanova, и др.
Опубликовано: (2021-01-01)

Parkinsonisms and Glucocerebrosidase Deficiency: A Comprehensive Review for Molecular and Cellular Mechanism of Glucocerebrosidase Deficiency
по: Emilia M. Gatto, и др.
Опубликовано: (2019-02-01)

Unveiling the Role of Cholesterol in Subnanomolar Ouabain Rescue of Cortical Neurons from Calcium Overload Caused by Excitotoxic Insults
по: Dmitry A. Sibarov, и др.
Опубликовано: (2023-08-01)

Structural determinants for subnanomolar inhibition of the secreted aspartic protease Sapp1p from Candida parapsilosis
по: Jiří Dostál, и др.
Опубликовано: (2021-01-01)

Comparative Study of Erythrocyte Sedimentation Rate after Aminoglycoside and Aminocyclitol Treatment in Goats (Capra hircus)
по: Toncho DINEV, и др.
Опубликовано: (2016-07-01)

Imino sugar therapy for type 1 Gaucher disease.
по: Priestman, D, и др.
Опубликовано: (2000)

N,Zn-Doped Fluorescent Sensor Based on Carbon Dots for the Subnanomolar Detection of Soluble Cr(VI) Ions
по: Enoch Kwasi Adotey, и др.
Опубликовано: (2023-02-01)